Figure 6
From: Clinical significance of extranodal extension in sentinel lymph node positive breast cancer
Kaplan–Meier curves depicting associations of ENE extent in SLN with DFS and OS in SLN positive patients with different nodal (N) stage. Comparison of survival rate for DFS (ENE ≤ 2 mm group vs. ENE > 2 mm group: P = 0.069) (A) and OS (ENE ≤ 2 mm group vs. ENE > 2 mm group: P = 0.411) (B) in patients with different size of ENE in SLN. Comparison of survival rate for DFS (ENE ≤ 2 mm group vs. ENE > 2 mm group: P = 0.338) (C) and OS (ENE ≤ 2 mm group vs. ENE > 2 mm group: P = 0.361) (D) between different ENE groups in patients with pN1 stage. Comparison of survival rate for DFS (ENE ≤ 2 mm group vs. ENE > 2 mm group: P = 0.554) (E) and OS (ENE ≤ 2 mm group vs. ENE > 2 mm group: P = 0.887) (F) between different ENE groups in patients with pN2 stage. Comparison of survival rate for DFS (ENE ≤ 2 mm group vs. ENE > 2 mm group: P = 0.261) (G) and OS (ENE ≤ 2 mm group vs. ENE > 2 mm group: P = 0.063) (H) between different ENE groups in patients with pN3 stage.
